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Purpose: To identify the causative genetic mutation among the known cataract candidate genes underlying the observed
phenotype in a Basotho family, with congenital nuclear cataracts.
Methods: Because of the small family size, we used the functional candidate gene analysis approach. We screened a
Basotho family, clinically documented to have congenital nuclear cataracts, for mutation in the candidate genes CRYG (C
& D; Crystallin, gamma C and Crystallin, gamma D), GJA8 (Gap junction protein, alpha 8), CRY (AA & AB; Crystallin,
alpha A and Crystallin, alpha B), CRYBA (Crystallin, beta A) and CRY (BB1 & BB2; Crystallin, beta B1 and Crystallin,
beta B2) through polymerase chain reaction analyses and sequencing.
Results: Mutation screening identified only one significant alteration in exon 6 (607G>A) of CRYBB2, with a substitution
of Valine to Methionine at position 187. This mutation segregated in all five affected family members but it was not
observed in any of the unaffected persons of the family. The putative mutation led also to the appearance of a new NIaIII
restriction site in the samples of the affected family members that was not present in 100 randomly selected DNA samples
from ophthalmologically normal individuals and in 40 unrelated senile cataract patients of the same ethnic background
as the family members.
Conclusions: This study identified a missense mutation in CRYBB2 in a family of Basotho with autosomal dominant
congenital cataract (ADCC). In summary, we believe this new missense allele is the probable causative molecular lesion
for the observed phenotype in this family.
Cataract is an opacification of the eye lens that frequently
results in visual impairment or blindness during infancy and
early childhood. On a global scale, cataracts are the leading
cause of blindness, accounting for approximately 48% of all
blindness  [1].  Around  three-quarters  of  the  world’s  blind
children live in developing countries in Africa and Asia [2].
Although congenital cataract is much less common than age-
related cataract, it is still responsible for approximately one
tenth  of  childhood  blindness  worldwide  [3].  Isolated
congenital cataracts tend to be highly penetrant Mendelian
traits,  with  autosomal  dominant  more  common  than
autosomal recessive and X linked inheritance cataracts [4].
Most progress has been made in identifying the genes
causing autosomal dominant congenital cataract [5]. Of the
cataract families for whom the mutant gene is known, about
half  have  mutations  in  crystallins,  about  a  quarter  have
mutations in connexins, with the remainder divided among the
genes  for  heat  shock  transcription  factor-4  (HSF4),
aquaporin-0 (AQP0, MIP), and beaded filament structural
protein-2 (BFSP2) [6,7].
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Crystallins are known to constitute about 90% of the
water-soluble  proteins  of  the  lens  and  contribute  to
transparency  and  refractive  properties  due  to  a  uniform
concentration gradient in the lens. The vertebrate crystallins
are divided into two families: α-crystallins and βγ-crystallins.
In  addition  to  being  refractive  proteins  in  the  lens,  α-
crystallins  are  molecular  chaperones  and  function  as
protective proteins against physiological stress [8]. Vertebrate
lens βγ-crystallins have two domains, each comprising two
structural motifs with signature folds called 'Greek keys' [9].
The relative position of the two domains in γB- and βB2-
crystallins (γB and βB2) differs in crystallographic structures,
having either ‘closed’ or ‘opened’ conformation, respectively
[10].  βγ-Crystallins  are  more  heterogeneous  with  seven
subunits (four acidic βA1-, βA2-, βA3-, and βA4-crystallin,
and  three  basic  βB1-,  βB2-,  and  βB3-crystallin)  in  the
heterooligomeric  β-crystallin  and  six  subunits  (γA-γF-
crystallin) in the monomeric γ-crystallin [11].
In the lens, crystallins interact to generate a gradient of
refractive index so that light can focus to the retina with
minimal scattering. Also protein interactions enhance protein
stability or solubility [11]. βB2 is the major β-crystallin in the
lens [12] and is the least modified during aging [13]. It is also
the most soluble of all the β-crystallins, remaining soluble
during aging [14], and is needed to maintain the solubility of
hetero-oligomers during isolation. There is a tendency for
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1470other β-crystallins to precipitate when separated from βB2.
This has led to the proposal of a role for βB2 in maintaining
the solubility of other β-crystallins that are heavily modified
during aging [15].
Crystallins are excellent candidate genes for inherited
cataracts  because  of  their  high  lens  expression.  Many
congenital cataract crystallin mutations have been reported; a
missense mutation in CRYBB2 (Q155X) has been identified
in three unrelated families with ADCC [16-18]. Interestingly,
the phenotype in each family is very different despite the
identical mutation indicating that other modifier genes are
likely  to  influence  the  cataract  phenotype  [19].  Another
mutation in βB2-crystallin, W151C has been reported recently
in human [20] and V187E in mice [21]. Herein, we report the
identification (by functional candidate gene analysis) of a
novel missense mutation (G607A) in exon 6 of CRYBB2 that
led to an exchange of Val for Met (V187M) as the probable
cause of the disease in this family. The majority of visually
impaired people live in developing countries, and since most
disorders  leading  to  visual  impairment  are  preventable  or
curable; their control is a priority in these countries. Better
understanding  of  genetic  and  environmental  influences  in
pathogenesis  of  congenital  and  infantile  cataract  in
developing  countries  may  highlight  the  importance  of
ophthalmic examination of parents and family members of
otherwise healthy children with cataract, to ensure hereditary
cases are not overlooked so that genetic counseling may be
provided. To our knowledge, this is the first reported case of
nuclear  cataracts  associated  with  the  CRYBB2  mutation
(V187M)  affecting  a  three-generation  Basotho  family  in
Lesotho.
METHODS
Clinical  evaluation:  The  three  generation  Basotho  family
(Figure  1)  was  enrolled  from  Maluti  Adventist  Hospital,
Lesotho. Written informed consent was obtained from all the
participating  family  members  or  their  parents  after
explanation of the nature and possible consequence of the
study in their native language. A detailed medical history was
obtained by interviewing all family members. Cataracts in
affected individuals were either present at birth or developed
during  childhood.  Affected  status  was  determined  by
ophthalmologic examination, which included visual acuity,
slit lamp and fundus examination with the dilated pupil. Slit
lamp examination of the affected lenses revealed a bilateral
nuclear  cataract  phenotype.  No  other  ocular  or  systemic
abnormalities were found upon physical examination in the
affected individuals except for index II:1, III:1 & III:2 (Figure
1), who also presented with strabismus.
Normal subjects and the senile cataract patients matching
the ethnic distribution of the family members were recruited
from  the  General  Ophthalmology  Clinic  of  the  Queen
Elizabeth II Hospital, Maseru, Lesotho. The senile cataract
patients also underwent full ophthalmologic examination the
same way as family members did. Patients with confounding
factors such as diabetes or other complicated eye diseases such
as glaucoma and uveitis were excluded from this study as the
diagnosis  criteria.  The  control  subjects  were  selected
randomly during routine medical fitness examination which
included visual acuity test. The research was approved by the
Zhongnan Hospital Research Ethics Committee and followed
the tenets of the Declaration of Helsinki.
Mutation screening: Blood samples were collected from all
the  study  subjects  and  spotted  (70  µl)  on  903®  specimen
collection paper (control no. A01798; Schleicher & Schuell
Inc., Keene, NH). Genomic DNA was isolated using standard
proteinase K/phenol method [22]. Briefly, four discs of about
6 mm in diameter were punched out from S&S 903 specimen
collection paper stained with dried blood. To prevent DNA
contamination,  the  paper  punch  was  sterilized  first  by
punching out a clean paper at least fifteen times and then by
alcohol burner flame after each separate paper punch. The
isolated  DNA  was  then  amplified  by  polymerase  chain
reaction (PCR) for the exons (and their flanking regions) of
CRYGC,CRYGD,CRYAA,CRYAB,CRYBA1,  CRYBB1,
CRYBB2 and GJA8. Primers for PCR amplification of exon 6
of the CRYBB2 were as follows: forward; 5'-CAC TGT GTC
CAA GGT CAC ACA GCT AAG C-3' and reverse; 5'-CCC
CTC GTT CAC CCT CCC ATC A-3'. The cycling conditions
for PCR included a 95 oC preactivation of the enzyme for 3
min, 10 cycles of touchdown PCR with a 1 oC decrement of
the annealing temperature per cycle from 70 oC to 61 oC, then
maintained at 60 oC for 20 more cycles. Each cycle consisted
of a denaturation at 94 oC, annealing step and extension at 72
oC, all for 30 s, with a final extension at 72 oC for 10 min. PCR
products  obtained  from  the  proband  and  one  unaffected
member of the family with these primers were sequenced
Figure 1. Family pedigree. The family history revealed five affected
members  in  three  generations.  The  dark  symbols  represent  the
affected members of the family, while the clear symbols indicate the
healthy ones. Circles are for female and squares for male family
members. Those who participated in this study are indicated with
asterisks. The arrow points to the proband. The pedigree of the family
suggests an autosomal dominant mode of inheritance.
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1471using ABI Genetic Analyzer 3730 (Invitrogene Ltd, Shanghai,
China). The sequencing results were analyzed using Chromas
2.3 and compared with the reference sequence in the NCBI
database. The mutation was confirmed by the presence of the
cleavage site for the restriction enzyme NIaIII (New England
BioLabs, Beijing, China) in the other participating affected
family members. For control, we analyzed 100 DNA samples
from  ophthalmologically  normal  individuals  of  the  same
ethnic background as the family members. The mutation was
further analyzed in 40 senile cataract patients by restriction
fragment length polymorphism. The resulted fragments were
resolved in 8% poly acrylamide gel electrophoresis (PAGE)
stained  with  silver  according  to  the  modified  protocol  of
Bassam et al. [23].
Protein  structure  analysis:  Biophysical  predictions  of  the
altered protein were analyzed using the Bioinformatics tool of
the  Expasy  Proteomics  server  [24].  Secondary  structure
prediction  was  carried  out  by  the  PHD  method  [25].  For
tertiary structure predictions, we used EsyPred3D [26] and
DEEP  VIEW/SWISS-Pdb  viewer  [27]  for  automated
homology  protein  modeling  and  visualization  of  resulting
protein database files. For hydropathy analysis we used Kyte-
Doolittle hydropathy plots. All hydropathies for both wild
type and mutant were calculated in a default window size of
7.
RESULTS
Case history: This three generation family included 5 affected
individuals with congenital nuclear cataract and 2 unaffected
individuals.  The  proband  (II:1),  a  44-year-old  male,  was
diagnosed with bilateral cataract at his first decade of life.
Later on, his female sib also complained of blurred vision in
her early teens. The two children (a girl and a boy) of the
proband and the son of the proband’s sister also suffered from
congenital cataract from birth. Apart from congenital cataract,
the proband and his two children (III:1 & III:2) also presented
with strabismus. All the affected individuals in this family
underwent cataract extraction so the lens photographs could
not be ascertained. A pedigree of the family is given in Figure
1.
Molecular analysis: In the course of functional candidate gene
analysis, polymorphic sites, rs2330992 & rs56123451 were
identified and since they did not co-segregate with the disease
phenotype in this family, they had to be excluded as causative
alleles for the mutation. However, bidirectional sequencing of
exon 6 of CRYBB2 in one of the affected individual (II:1)
showed a heterozygous change at position 607 (c. 607G→A)
(Figure 2A). In contrast, the mutation was not seen in a healthy
family  member  (III:4)  (Figure  2B).  The  mutation  was
confirmed by an NIaIII digest of the PCR amplified exon 6 of
CRYBB2. The same alteration was found in the four other
family members who were also affected (II:3, III:1, III:2, and
III:3) but was not observed in the healthy family members
tested nor in the 100 unrelated control subjects and 40 senile
cataract patients from the same Basotho population (Figure
2C). This nucleotide substitution replaced an evolutionarily
highly  conserved  Valine  with  Methionine  at  amino  acid
position 187 (p.V187M) in the fourth Greek key motif of βB2
crystallin (Figure 2D).
Bioinformatics  and  structure  predictions:  The  secondary
structure of the mutant CRYBB2 compared with the wild type
was determined by the PHD method which predicted that, the
Figure  2.  Mutation  analysis  of  CRYBB2.  The  sequence
chromatogram  of  a  mutant  allele  shows  a  heterozygous  G→A
transition that changed Valine at codon 187 to Methionine (counting
the  A  of  the  ATG  start  codon  as  number  1;  A).  The  sequence
chromatogram of a wild type allele shows Valine (GTG) at codon
187(B). Restriction fragment length analysis showing that a gain of
the  novel  NIaIII  site  cosegregated  with  affected  individuals
heterozygous with the V187M mutation (300, 168, and 150 bp) but
not with unaffected individuals (300 and 168 bp). C demonstrates an
unrelated  healthy  individual.  D:  Sequences  producing  specific
alignment  of  CRYBB2  amino  acids.  A  protein–protein  BLAST
search (NCBI) of human βB2-crystallin amino acid sequence was
done. Proteins having various levels of sequence identity were picked
and manually aligned. Shaded letters (yellow) correspond to amino
acid that is mutated in this study (highlighted in red).
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1472mutant appears to have more α-helical secondary structure
content (at amino acid 187 and 192) and less β-strands than
the wild-type. In total, 5.85% of the protein is α-helix, all other
regions  are  predicted  to  be  randomly  coiled  (65.37%)  or
extended  β-strands  (28.78%)  for  the  mutant,  and  4.88%,
64.88%,  and  30.24%,  respectively  for  the  wild  type.
Molecular  modeling  predicted  changes  in  electrostatic
potential that would be expected to reduce the stability of the
fourth Greek-key motif. The negative potential around residue
M187 in the mutant protein is markedly enlarged (Figure
3A,B).  Furthermore,  Kyte-Doolittle  algorithms  for
hydrophobicity analysis showed significant variation in the
physicochemical properties of the critical region in the mutant
form  compared  with  the  wild  type.  The  environment
surrounding the amino acid “Valine 187” in the wild-type
protein is neutral (boxed region). In contrast, in the mutant
form  the  hydropathy  environment  has  become  more
hydrophilic, with calculated values ranging from 0 to -1.145
(Figure 3C,D).
DISCUSSION
In the β-crystallins, individual Greek key motifs are encoded
by separate exons. The Cryb genes consist of six exons: The
first exon is not translated, the second exon encodes the NH2-
terminal  extension,  and  the  subsequent  four  exons  are
responsible for one Greek key motif each [21]. By molecular
screening  of  β/γ-crystallin  genes,  in  the  three  generation
family  of  Basotho  with  ADCC,  we  finally  identified  a
sequence  variation  (GA)  within  exon  6  of  Crybb2.  The
corresponding alteration at the amino acid level (Val187Met)
is thought to affect the formation of the fourth Greek key motif
of the βB2-crystallin. The mutation is located in the (sixteenth
β strand) β4-sheet of the fourth Greek key motif of the protein,
a  region  crucial  to  the  correct  formation  of  the  tertiary
structure of the βB2-crystallin, even if previous structural
examination of the COOH-terminal region focused on the
amino acids from 173 to 185, but did not include Val187
[28].  Improper  folding  of  CRYBB2,  the  most  abundantly
expressed β-crystallin in the lens, could well cause protein
aggregation and result finally in the cataract. Although the
function of the Greek key motif is still a matter of debate,
computer-based  analysis  suggests  that  they  form  an
interdomain association – intramolecular in the -crystallins,
and intermolecular in the β-crystallins. In this way, they allow
a dense packaging of the proteins minimizing light scattering,
but providing an optimum in transparency of the eye lens
[29]. βB2-Crystallin is the most abundant β-crystallin in the
human lens and is important in formation of the complex
interactions of lens crystallins. The CRYBB2V187M in this case
could have possibly destabilized the complex formation that
is critical for lens transparency. A second functional aspect of
the Greek key motif is its Ca2+ binding properties [29]. In
conditions of stress, it may be important for the β-crystalline
to be recruited into the cytoplasm to stabilize other proteins
via its high beta sheet content, and/or to ensure that storage
levels of cytoplasmic Ca2+ are maintained [30].
Due  to  their  long  life  spans,  crystallins  undergo  an
unusually large number of modifications with deamidation
being a major factor. All modifications except one involve
oxidation  of  either  methionine,  cysteine,  or  tryptophan
residues. In human congenital cataracts, expression of specific
genetic  mutations  of  crystallin  genes  causes  changes  in
protein–protein  interaction  and  subsequent  protein  density
fluctuations, but at a younger age over a much shorter time
period [31]. The CRYBB2V187M identified in our family with
ADCC results in loss of a valine residue in the fourth motif of
the  COOH-terminal  domain.  A  protein–protein  BLAST
search (NCBI) of human βB2-crystallin amino acid sequence
shows  that  valine  is  absolutely  conserved  in  the  COOH-
terminal domain (Figure 2D). The removal of a valine residue
from  a  highly  conserved  structural  domain  is  likely  to
facilitate  further  modifications  and  may  contribute  to
Figure 3. Structural analysis of the mutant protein. The predicted
three-dimensional  protein  structures  for  CRYBB2WT  (A)  and
CRYBB2V187M (B), without side chains. The electrostatic potential
is displayed in red (negative potential) and blue (positive potential)
clouds. The mutant protein exhibits an unusually large negative
electrostatic potential (green arrow). The amino acid V187 in the
wild type is marked in red and in the mutant form, M187 is marked
in green. Kyte-Doolittle hydropathy plot of CRYBB2WT (C) and
CRYBB2V187M (D). X-axis represents position of amino acids. Y-
axis represents hydropathy value in a default window size of 7.The
region  of  interest  is  marked  by  white  boxes.  The  increase  in
hydrophilicity in the mutant form is evident.
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1473compromised  ability  of  βB2-crystallin  to  maintain  the
solubility of other more modified β-crystallins. This is in
keeping with the observation by Liu and Liang [32], that
mutations in Val-152, Leu-165, and Val-187 destroyed β13-,
β14-,  and  β16-strands  located  in  the  motif-4  critical  in
dimerization and resulting in the large reduction in SEAP
activity (reduced protein-protein interation). The β16-strand of
the  fourth  Greek  key  motif  is  affected  in  the  new  allele
reported here.
Finally,  an  even  more  striking  consequence  is  the
modification of the electrostatic potential in this area. The
mutant  protein  exhibits  a  strikingly  enlarged  negative
potential  in  this  region  (Figure  3B).  This  might  be  the
electrostatic  explanation  for  the  predicted  change  of  the
hydrophobic nature from neutral (0) to -1.145 in this region
(Figure  3C,D).  It  is  a  matter  for  speculation  whether  the
increase in hydrophilicity of the altered βB2-crystallin could
be due to the oxidation of M187 probably by interacting with
water by hydrogen bonding, potentially causing loosening or
partial unfolding of the hydrophobic clusters in the protein.
Nevertheless,  further  physico-chemical  experiments  are
necessary  to  explore  the  underlying  molecular  and
biochemical mechanisms in details. A corresponding mouse
counterpart to the human mutants at the Crybb2 gene locus is
the  Philly  and  Crybb2Aey2  mutations  which  lead  to  a
progressive dominant cataract although the progression was
slower in the Aey2 mutant than in the Philly probably because
of the smaller molecular lesion in the Aey2 mice [21]. The
mutation in our family affects also the same region of the
protein (close to the carboxyl-terminus) as does the Crybb2Aey2
mutation (Figure 4).
In  conclusion,  we  identified  a  missense  mutation  in
CRYBB2  (V187M)  that  is  associated  with  autosomal
dominant nuclear congenital cataract in a three generation
Basotho family. The V187M substitution is thought to affect
the  formation  of  the  fourth  Greek  key  motif  of  the  βB2-
crystallin, potentially disturbing the integrity of the subunit
Figure  4.  A  schematic  overview  of  the  mutations  identified  in
Philly, Aey2, and index II:1 (in our study). The mutation in Philly is
indicated by a shaded rectangle; the exchanged amino acid is noted
below the sequence in Aey2 and above the sequence in II:1.
interaction domains which is important in sustaining their
stability  and  or  dimerization.  However,  the  mechanisms
underlying the molecular process of cataract formation still
remain unclear and need further study.
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